🇺🇸

US SEC Filing Intelligence

· daily

US Executive Officer Management Changes SEC — September 11, 2026

The September 11, 2026, digest reveals a high volume of executive and director changes, with 32 filings processed. A key theme is the prevalence of voluntary departures and retirements, often with no disclosed disagreements, suggesting routine churn but also potential underlying talent retention challenges. Notable negative signals include a sharp 94.1% decline in net income at AMREP Corp. and a contentious board resignation at BioRestorative Therapies triggering a potential $1.29 million severance dispute. Positive developments include strategic leadership restructuring at Celestica to capitalize on 'unprecedented growth' and the appointment of a seasoned CFO at Oportun Financial. Insider activity is limited, but shareholder dissent on equity plan amendments at NetScout Systems and Artiva Biotherapeutics signals governance concerns. The data suggests a bifurcated market where strong companies are proactively restructuring for growth, while others face operational and governance headwinds.

32 high priority 32 total filings
· daily

US Corporate Board Director Changes SEC Filings — September 11, 2026

Today's USA Board Room Changes digest reveals a high volume of CFO and C-suite departures, with 12 officer changes across 32 filings, signaling potential operational instability at several firms. Notable trends include a wave of CFO transitions at Celestica, Oportun, and Coty, where internal promotions and strategic restructurings suggest proactive succession planning. However, several filings carry negative sentiment, including a disputed resignation at BioRestorative Therapies triggering a $1.29M severance claim and a 94% net income plunge at AMREP. Insider activity is sparse, but shareholder dissent on equity plan amendments at Artiva Biotherapeutics (17.3% against) and Peraso (38.6% against) flags governance concerns. The mix of routine retirements and sudden exits creates a bifurcated landscape of stable leadership transitions versus high-risk governance disruptions.

32 high priority 32 total filings
· daily

USA Insider Trading Pulse — September 11, 2026

The September 11, 2026 insider trading pulse reveals a market with divergent insider sentiment: a cluster of high-conviction insider buying in small-cap and micro-cap names (Relmada Therapeutics, Angel Studios, Group 1 Automotive) contrasts with significant, pre-planned selling in high-growth tech (Sea Ltd, Zoom Communications) and insider selling in struggling healthcare (Sera Prognostics). A notable pattern is the coordinated option exercise and pledge activity at JAKKS Pacific, which may signal capital management rather than directional conviction. The data shows a clear sector divide: life sciences and select financials are seeing insider accumulation, while consumer tech and micro-cap diagnostics are experiencing insider distribution. The most actionable signals come from the magnitude of insider purchases at Angel Studios ($1.88M) and Group 1 Automotive ($6.62M), which dwarf other transactions and suggest strong fundamental conviction. Overall, the pulse indicates selective opportunity in beaten-down sectors with insider support, while caution is warranted for names with persistent 10b5-1 selling programs.

49 high priority 1 medium 50 total filings
· daily

US Merger & Acquisition SEC Filings — September 11, 2026

The September 11, 2026, filing batch reveals a bifurcated M&A landscape: high-conviction de-SPAC mergers (Cyclerion/Korsana, Athena/Ace Green) are closing with strong shareholder support and significant capital raises, while several SPACs (Ribbon, Quetta, Columbus) are showing signs of distress with massive redemptions, repeated extensions, and adjournments. The most transformative event is New Fortress Energy's restructuring, which extinguished ~$5.7B in debt and created two standalone entities, representing a massive balance sheet repair. A notable cross-border deal emerged with ChampionsGate's $80M EV acquisition of Korean safety diagnostics firm Futuremain, while Volato's amended merger with Aligned Engine at a $500M valuation shows deal terms are being renegotiated upward. The data reveals a clear pattern: SPACs with strong institutional backing and tangible assets are closing successfully, while those without are struggling to maintain trust account balances. Period-over-period comparisons show no revenue trends as most filers are pre-revenue SPACs or restructuring entities, but the capital allocation trends are stark—$475M in new cash for Korsana vs. $36.3M in redemptions draining Ribbon's trust.

19 high priority 19 total filings
· monthly

US Pre-Market SEC Filings Roundup — September 11, 2026

The overnight filing set presents a mixed picture for U.S. markets, characterized by significant insider selling at high-growth biotechs and a wave of capital structure changes. A key macro theme is the growing financial strain in the biotechnology sector, with CEOs at Protagonist Therapeutics and Roivant Sciences executing large pre-planned stock sales, while Nauticus Robotics secures a one-year debt extension, signaling ongoing cash burn. Conversely, industrial and technology companies like LightPath Technologies and Descartes Systems Group are reporting robust revenue growth driven by secular tailwinds (defense, supply chain logistics). Notable capital markets activity includes a $1.3 billion dual-tranche debt offering by Thomson Reuters and a $900 million high-yield issuance by Wynn Resorts, contrasting with a $56.5 million debt-for-equity exchange at Impinj. A prominent sector theme is the continued activity in the SPAC market, with several filings advancing de-SPAC mergers with companies in biotech (Oak Hill Bio) and space technology (Gravitics), alongside a proposed public listing of the BIG3 basketball league.

24 high priority 26 medium 50 total filings
· daily

Federal Construction & Infrastructure Contracts — September 10, 2026

This digest covers three civilian federal construction contracts totaling $177.6 million, with zero defense exposure, signaling a concentrated investment opportunity in non-defense infrastructure. The dominant theme is Department of the Interior water and park infrastructure spending, led by a $72.9 million Bureau of Reclamation pipeline award to Carstensen Contracting Inc., which represents the highest-conviction signal due to its materiality and alignment with long-term water resource priorities. A key risk is the fixed-price nature of all three contracts, which exposes contractors to cost-overrun risk, particularly for Record Steel and Construction's $46.2 million Yellowstone water treatment project, where only 15% of funds have been outlayed. Investors should monitor option exercises and outlay rates as leading indicators of execution quality and cash flow.

3 total filings
· daily

DHS Homeland Security Contracts — September 10, 2026

In the period September 10, 2026, DHS awarded $612.9M across four contracts, all civilian, with a dominant theme of border security and IT modernization. The highest-conviction signal is OSI Systems' $88.1M fully-funded, firm-fixed-price delivery order for non-intrusive inspection systems, showing strong execution and long-term visibility. Accenture Federal Services' $370.1M cost-plus data center contract carries execution and foreign-ownership risk, while MAXIMUS and General Dynamics add stable, competitive wins. Key watch item: option exercises and DHS budget appropriations for FY2027-2029 will determine revenue durability.

4 total filings
· daily

VA Healthcare & Services Contracts — September 10, 2026

The September 10, 2026 VA Healthcare & Services contract stream totals $370.3 million across three awards, all civilian (0/3 defense-related), underscoring the Department of Veterans Affairs' sustained investment in cybersecurity, infrastructure, and energy efficiency. The highest-conviction signal is MAVERIS LLC's $217.8 million cybersecurity operations center delivery order (potential $331.2M with options), reflecting robust demand for VA cyber defense despite a neutral signal strength of 6/10. Key risks include firm-fixed-price execution exposure on long-duration contracts (MAVERIS through 2028, LEO A. DALY through 2027, UTILITY SYSTEMS SOLUTIONS through 2049) and the fact that UTILITY SYSTEMS SOLUTIONS has $0 outlayed to date, signaling potential funding or execution delays. The aggregate signal strength is neutral (5.0/10), with no bullish or bearish signals, indicating a steady but unremarkable procurement environment for VA services.

3 total filings
· daily

HHS & Healthcare Contracts Intelligence — September 10, 2026

This digest covers six HHS contracts totaling $1.31B, with only one defense-related award (ADVANCED TECHNOLOGY INTERNATIONAL at $1.01B), skewing the portfolio heavily toward civilian health R&D. The dominant theme is NIH/NIAID and BARDA funding for pandemic preparedness and biodefense, with five of six contracts supporting serological research, vaccine development, and medical countermeasure platforms. The highest-conviction signal is Leidos Holdings' $79.9M SeroNet win, which shows competitive strength in health R&D but represents a modest revenue contribution. Key risk: the $1.01B ADVANCED TECHNOLOGY INTERNATIONAL contract lacks pricing and competition details, creating opacity around its true profitability and competitive moat.

6 total filings
· daily

New Federal Contractors — September 10, 2026

This digest of 23 new federal contracts, totaling $2.83 billion, reveals a pronounced civilian agency spending bias, with only two defense-related awards. The Department of Health and Human Services (HHS) dominates, driven by a single $1.01 billion award to ADVANCED TECHNOLOGY INTERNATIONAL, which accounts for over a third of the total obligation and is the highest-conviction signal. While the aggregate is large, the signal strength is moderate (5.7/10), and the digest is characterized by neutral signals (16 of 23) and a lack of bearish flags. Key risks include the heavy concentration in HHS and the vulnerability of contracts awarded in late September to Continuing Resolution uncertainty. The most actionable bullish signal is OSI Systems' $88.1 million DHS award for border inspection systems, which offers high visibility and strong execution.

23 total filings
· daily

Significant Contract Modifications ($10M+) — September 10, 2026

This digest synthesizes 23 government contract modifications totaling $2.83 billion, predominantly from civilian agencies (21 of 23 contracts), with only two defense-related awards. The Department of Health and Human Services (HHS) dominates, led by a $1.01 billion sole-source award to ADVANCED TECHNOLOGY INTERNATIONAL, which accounts for 36% of aggregate value but lacks public revenue data, raising transparency concerns. The highest-conviction bullish signal is OSI Systems’ $88.1 million Rapiscan Systems delivery order from DHS/CBP for border inspection systems, with strong execution visibility and long-term service tail. Key risks include concentration in opaque or private entities (e.g., ADVANCED TECHNOLOGY INTERNATIONAL, INDEX ANALYTICS LLC) and potential budget disruption from Continuing Resolution uncertainty affecting October-December awards. Investors should monitor DHS border security spending, VA cybersecurity contract options, and NIH R&D pipeline for follow-on awards.

23 total filings
· daily

Contract Deobligations Alert — September 10, 2026

The 23 contracts totaling $2.83B are overwhelmingly civilian (21 of 23), with only 2 defense-related awards, signaling a continued shift toward civilian agency spending in health, homeland security, and infrastructure. The dominant theme is IT and cybersecurity services, led by a $1.01B HHS award to Advanced Technology International and significant DHS/CBP border security technology contracts to OSI Systems ($88.1M) and General Dynamics ($72.8M). The highest-conviction bullish signal is OSI Systems' fully-funded $88.1M delivery order with strong execution ($81M outlaid), while the key risk is the concentration of large awards in civilian agencies, which may face budget volatility under a continuing resolution. Watch for option exercises on the MAXIMUS TSA contract ($170.97M potential) and the General Dynamics surveillance contract ($115M potential) as key catalysts.

23 total filings
· daily

Contract Option Exercises — September 10, 2026

This digest of 23 contract option exercises totaling $2.83 billion reveals a pronounced civilian-agency tilt, with only 2 of 23 contracts defense-related, underscoring the current Continuing Resolution (CR) vulnerability for defense awards in the October-December window. The Department of Health and Human Services dominates, led by a $1.01 billion sole-source award to ADVANCED TECHNOLOGY INTERNATIONAL, which alone accounts for 36% of aggregate value and carries the highest materiality score (8/10). The highest-conviction bullish signal is OSI Systems' $88.1 million Rapiscan Systems border security win, reflecting durable DHS investment in non-intrusive inspection technology. Key risk: 16 of 23 contracts are neutral-rated, with 7 carrying medium pricing risk from firm-fixed-price structures, and the aggregate average signal strength of 5.7/10 suggests limited near-term catalysts for most contractors.

23 total filings
· daily

Federal Professional Services Contracts — September 10, 2026

The sole contract in this digest is a $52.96 million firm fixed-price award from the Department of Labor to Paragon Technical Services, Inc., a small disadvantaged and veteran-owned business, for administrative management consulting services. This is a civilian agency contract, with no defense-related awards in the period. The contract represents a significant revenue opportunity for Paragon, with a potential value of $67.70 million if all options are exercised, and signals stable demand for management consulting services within the Department of Labor. The highest-conviction signal is the multi-year revenue stream for Paragon, though the firm fixed-price structure introduces performance risk. Key watch items include the exercise of contract options and Paragon's execution under the fixed-price terms.

1 total filings
· daily

Federal IT & Cybersecurity Contracts — September 10, 2026

This digest covers $914.4 million in federal IT and cybersecurity contracts awarded between 2017 and 2025, with only 1 of 8 contracts defense-related (DHS/CBP), signaling a civilian-heavy stream. The dominant agency theme is Department of Health and Human Services (HHS/CMS), accounting for $141.6 million across three awards to INDEX ANALYTICS, CIVICACTIONS, and SPARKSOFT. The highest-conviction signal is MAXIMUS Federal Services’ $170.97 million TSA OPTIMA support contract, which reinforces its position in mission-critical DHS IT services. A key risk is the $370 million Accenture Federal Services DHS data center contract, where only $64 million has been outlayed and 55% is subawarded, raising execution and margin dilution concerns. Overall, the stream is neutral with 3 bullish signals, 0 bearish, and 5 neutral, reflecting stable civilian agency IT spending but limited defense exposure and modest profit upside due to fixed-price and cost-plus structures.

8 total filings
· daily

NASA & Space Contracts Intelligence — September 10, 2026

This single-contract digest covers a $47.7M non-competitive cost-plus-fixed-fee delivery order from NASA to the California Institute of Technology for terrestrial ecology and carbon cycle research, with no defense-related content. The award is purely civilian, aligning with NASA’s long-term Earth science priorities, but its low materiality (3/10) and neutral signal limit actionable investment insights. The key takeaway is that Caltech benefits from stable, low-risk revenue through 2027, though the lack of competition or commercial applicability reduces broader market relevance. A notable risk is the absence of competitive validation, which could mask inefficiency or budget vulnerability in future NASA science procurements. Given the N/A competition status, investors should watch for any shift toward competitive awards in NASA’s Earth science portfolio as a potential catalyst for other research contractors.

1 total filings
· daily

All HHS Contracts — September 10, 2026

The 9 HHS contracts totaling $1.46 billion reveal a civilian-heavy procurement stream overwhelmingly focused on health R&D and IT services, with only one defense-related award ($1.01B to ADVANCED TECHNOLOGY INTERNATIONAL) dominating the aggregate value. The dominant theme is NIH/NIAID and BARDA-funded biomedical research and pandemic preparedness, accounting for ~$304M across five contracts to Leidos Biomedical Research, BIOQUAL, Fisher Bioservices, JHU/APL, and Draper Laboratory. The highest-conviction signal is the $1.01B sole-source defense contract to ADVANCED TECHNOLOGY INTERNATIONAL, which represents 69% of total value but lacks pricing and competition details, creating significant uncertainty. Key risk: the ADVANCED TECHNOLOGY INTERNATIONAL award is opaque, and the remaining contracts are cost-plus with capped margins, limiting upside for investors despite stable revenue visibility.

9 total filings
· daily

Mega Contracts Monitor ($100M+) — September 10, 2026

The September 10, 2026 mega-contract stream (3 awards, $1.60B total) is entirely civilian, with zero defense-related obligations, underscoring sustained federal investment in IT and cybersecurity services across HHS, DHS, and VA. The dominant theme is large-scale civilian IT infrastructure and security spending, led by a $1.01B HHS award to Advanced Technology International (ATI) — the highest-conviction signal (bullish, 7/10) — while Accenture Federal Services' $370M DHS/CBP data center contract and Maveris LLC's $217.8M VA cybersecurity order add diversification but carry execution and pricing risks. Key watch items include the VA's $113.3M in unexercised options and the DHS contract's June 2023 end date, which may trigger recompetes. The absence of defense contracts suggests near-term DOD spending is not a driver in this stream, but civilian IT services remain a resilient growth pocket.

3 total filings
· daily

High-Value Federal Grants ($5M+) — September 10, 2026

The 23 high-value federal grants totaling $2.83 billion are overwhelmingly civilian, with only 2 defense-related contracts, signaling sustained non-defense spending in health, homeland security, and infrastructure. The Department of Health and Human Services (HHS) dominates, accounting for over half of the total value, led by a $1.01 billion award to Advanced Technology International. The highest-conviction signal is OSI Systems' $88.1 million DHS/CBP inspection systems contract, which shows strong execution with 92% of funds already outlaid. Key risks include the concentration of HHS awards, the potential for budget volatility under continuing resolutions, and execution risks on large fixed-price infrastructure contracts. Investors should watch for option exercises on MAXIMUS, General Dynamics, and Leidos contracts, as well as the re-compete of Accenture's DHS data center contract.

23 total filings
· daily

General Federal Contracts — September 10, 2026

This digest of 23 federal contracts, totaling $2.83 billion, reveals a pronounced civilian agency focus, with only 2 of 23 awards defense-related, underscoring a non-defense procurement cycle. The Department of Health and Human Services (HHS) dominates, led by a $1.01B award to ADVANCED TECHNOLOGY INTERNATIONAL, though data gaps limit its assessment. The highest-conviction bullish signals come from OSI Systems (Rapiscan) and General Dynamics, both securing border security contracts from DHS/CBP, indicating sustained investment in surveillance and inspection technology. A key risk is the high number of neutral signals (16 of 23), reflecting uncertainty from fixed-price contracts, small business set-asides, and long performance periods that may not translate to near-term shareholder value. Investors should watch for option exercises on the MAXIMUS and OSI Systems contracts as key catalysts, while monitoring execution risk on the large fixed-price awards to MAVERIS LLC and PARAGON TECHNICAL SERVICES.

23 total filings